News
Your source for the latest updates, breakthroughs, and insights in drug development and manufacturing. Explore our featured stories, press releases, and event announcements to stay informed about our innovations and contributions to drug development and manufacturing advancements.
News
Your source for the latest updates, breakthroughs, and insights in drug development and manufacturing. Explore our featured stories, press releases, and event announcements to stay informed about our innovations and contributions to drug development and manufacturing advancements.
Avance Biosciences to Exhibit at Advanced Therapies USA 2026
Avance Biosciences will exhibit at Advanced Therapies USA 2026, highlighting cell and gene therapy characterization and release testing, viral vector testing, gene editing on/off-target analysis, and CMC-aligned testing support. Visit our team at Booth #511 to discuss analytical strategies for your cell and gene therapy program...
FDA Finalizes Potency Assurance Guidance for Cell and Gene Therapy Products
FDA has finalized its Potency Assurance guidance for cell and gene therapy products, replacing the 2011 potency testing guidance with a lifecycle-wide, risk-based strategy. The final guidance carries over the December 2023 draft’s structure largely unchanged, with targeted updates including new flexibility for alternative risk assessment approaches and reference materials...
Avance Biosciences to Exhibit at AAPS PharmSci 360 2026
Avance Biosciences will exhibit at AAPS PharmSci 360 2026, highlighting bioanalytical method development and validation, immunogenicity (ADA) testing, biomarker and PK/PD testing, and potency and biologics characterization. Visit our team at Booth #1643 to discuss analytical strategies for your development program...
Avance Biosciences Launches AI Drug Discovery Wet Lab Services
Avance Biosciences now offers wet-lab analytical support for AI drug discovery teams, turning computational predictions into experimental data that can be validated and fed back into models. Backed by automated workflows, an API-connected LIMS and a GLP and cGMP-grade quality system, the service helps AI-first biotechs move from promising candidates to proven results.
Avance Biosciences to Exhibit at SITC 2026
Avance Biosciences™ is excited to announce that we will be exhibiting at the Society for Immunotherapy of Cancer's (SITC) 41st Annual Meeting, taking place November 4–8, 2026 at the Phoenix Convention Center in Phoenix, [...]
Bioprocess and Cell & Gene Therapy International 2026
Avance Biosciences will exhibit at BioProcess International and Cell & Gene Therapy International 2026, highlighting analytical support for mRNA therapeutics and RNA vaccines, on/off-target analysis, biodistribution analysis, whole genome sequencing, and potency testing. Visit our team at Booth #1402 to discuss analytical strategies for advancing biologics and next-generation therapies...
